IRME.OTC.PinkIr-med, INC

8-K: IR-Med Reports $500,000 Payment Default from Key Investor, Prepares Legal Action

Sentiment:

Investment Dispute Update


IR-Med, Inc. announced that Williamsburg Venture Holdings, LLC failed to remit a $500,000 payment for common stock as per their Equity Purchase Agreement, prompting the company to pursue legal enforcement.

Delay expectedWilliamsburg Venture Holdings, LLC failed to timely deliver the $500,000 payment for the put shares as required by the agreement.
Capital raiseAn Equity Purchase Agreement was established on March 11, 2025, for Williamsburg Venture Holdings, LLC to invest up to $15,000,000 in IR-Med, Inc. over a 24-month period.A $500,000 tranche of this agreed-upon investment, relating to the sale of 4,629,630 shares, has not been remitted by Williamsburg, indicating a partial failure of the capital raise.
Worse than expectedWilliamsburg Venture Holdings, LLC failed to remit a required $500,000 payment for common stock, representing a breach of a significant investment agreement.The company has not received any response from Williamsburg's Managing Member regarding the payment default, indicating a lack of communication and cooperation.IR-Med is now forced to pursue legal action to enforce the agreement, which introduces additional costs, time, and uncertainty for the company.

Summary

  • IR-Med, Inc. and Williamsburg Venture Holdings, LLC entered into an Equity Purchase Agreement on March 11, 2025, for Williamsburg to invest up to $15,000,000 over a 24-month period.
  • On May 30, 2025, IR-Med delivered a put notice to Williamsburg for the sale of 4,629,630 shares of common stock at a per share price of $0.108, totaling an aggregate purchase price of $500,000.
  • IR-Med fulfilled its obligations under the agreement, including the timely delivery of the put shares.
  • Williamsburg Venture Holdings, LLC has failed to remit the required $500,000 payment.
  • IR-Med has made multiple attempts to contact Mr. Ronald Glenn, the Managing Member of Williamsburg, regarding the payment failure but has not yet received a response.
  • IR-Med intends to continue seeking payment for the put shares and will pursue any legal means available to enforce the terms of the Agreement.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant payment default from an investment partner, forcing the company to pursue legal action and creating uncertainty regarding future funding tranches from the same agreement. This introduces financial and operational risks.

Positives

  • NA

Negatives

  • Williamsburg Venture Holdings, LLC failed to remit a required $500,000 payment for 4,629,630 shares of common stock.
  • The company has not received a response from Williamsburg's Managing Member despite multiple contact attempts regarding the overdue payment.
  • IR-Med is now compelled to pursue legal action to enforce the terms of the Equity Purchase Agreement, which may incur additional costs and time.

Risks

  • Financial shortfall due to the unreceived $500,000 payment, potentially impacting liquidity and operational plans.
  • Potential costs and time associated with legal proceedings to enforce the Equity Purchase Agreement.
  • Uncertainty regarding the remaining tranches of the potential $15,000,000 investment from Williamsburg Venture Holdings, LLC.
  • Reputational risk associated with a failed investment agreement and the need for litigation.

Future Outlook

The company intends to continue seeking the $500,000 payment from Williamsburg Venture Holdings, LLC and plans to pursue any available legal means to enforce the terms of the Equity Purchase Agreement.

Management Comments

  • "The Company fulfilled its obligations pursuant to the terms of the Agreement, including the timely delivery of the put shares."
  • "To date, Williamsburg has failed to remit the required $500,000 owed pursuant to the terms of the Agreement."
  • "The Company has made multiple attempts to contact Mr. Ronald Glenn, the Managing Member of Williamsburg, with respect to Williamsburgs failure to timely deliver the payment for the put shares, but to date has not yet received a response."
  • "The Company will continue to seek payment for the put shares from Williamsburg and intends to pursue any legal means available to it to enforce the terms of the Agreement."

Industry Context

This event highlights the inherent risks associated with reliance on specific investment agreements, particularly for smaller companies that may depend on such capital infusions for operations or growth. It underscores the importance of robust legal frameworks and the potential for disputes in investment partnerships within the broader financial and corporate landscape.

Comparison to Industry Standards

  • NA

Legal Proceedings

  • The company intends to pursue any legal means available to it to enforce the terms of the Equity Purchase Agreement against Williamsburg Venture Holdings, LLC due to their failure to remit a $500,000 payment for common stock.

Stakeholder Impact

  • Shareholders: Face uncertainty regarding the company's liquidity and future funding, potential dilution if shares were already issued without payment, and the costs/risks associated with potential litigation.
  • Company Operations: May experience a shortfall in expected capital, potentially impacting operational plans or growth initiatives that relied on the $500,000 payment.

Next Steps

  • Continue to seek the $500,000 payment from Williamsburg Venture Holdings, LLC.
  • Pursue any legal means available to enforce the terms of the Equity Purchase Agreement.

Key Dates

DateDescription
March 11, 2025Date of the Equity Purchase Agreement between IR-Med, Inc. and Williamsburg Venture Holdings, LLC.
May 30, 2025Date IR-Med, Inc. delivered a duly executed put notice to Williamsburg Venture Holdings, LLC for the sale of $500,000 worth of common stock.
July 11, 2025Date of earliest event reported and filing date of the Form 8-K, detailing Williamsburg's failure to remit payment.

Recommendation

sell

Keywords

IR-Med, Williamsburg Venture Holdings, Equity Purchase Agreement, payment default, breach of contract, common stock, investment, SEC filing, 8-K, litigation, financial reporting, corporate finance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.